JOHN PEARSON: Open Payments
NPI 1962400655 · CAMDEN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 69 payments from 15 companies in 2025. Trend: 2023 $1,091 · 2024 $1,740 · 2025 $1,323
Food & beverage: $1,323
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $291 |
| Novo Nordisk Inc | 17 | $288 |
| GlaxoSmithKline, LLC. | 9 | $137 |
| Abbott Laboratories | 5 | $113 |
| PFIZER INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Exact Sciences Corporation | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 4 | $52 |
| Astellas Pharma US Inc | 3 | $49 |
| ABBVIE INC. | 2 | $48 |
Products named: BREZTRI, Ozempic, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, AIRSUPRA, CAPLYTA, VOQUEZNA, Veozah.
Industry payments across DE — which companies pay providers there.
